Event-Driven Stocks

Calithera Biosciences, Inc.

CALA

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs1 good2 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20FY19FY18FY17
Revenue$9.8M$22.3M$26.0M
Operating income−$42.1M−$115.4M−$91.4M−$92.9M−$57.3M−$29.7M
Net income−$39.6M−$115.1M−$90.1M−$89.9M−$54.6M−$27.8M
Total assets$28.7M$64.8M$125.6M$168.8M$142.7M$192.5M
Total liabilities$8.3M$15.7M$23.2M$26.3M$16.0M$42.1M
Equity$20.4M$8.4M$102.4M$142.4M$126.7M$150.3M
EPS (diluted)$-7.94$-31.16$-26.20
Shares out.78.7M73.3M64.7M38.8M35.8M27.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
Net margin
Return on equity
−194.4%
Return on assets
−138.3%
Return on capital (ROCE)
−197.7%
Liabilities / assets
28.9%
Debt / equity
0.41×
Book value / share
$0.26
Revenue growth (YoY)
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-61.15distress
Accruals / assets
13.8%high accruals
Piotroski F-Score
1/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
27
/ 100
Profitability 0Growth n/aCatalyst 33Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

2 severe2 warning1 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Conservative leverage (liabilities < 50% of assets)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20267,3297.7-0.0%
Apr 30, 20267,3303.0+8.2%
Apr 15, 20266,77413.50.0%
Mar 31, 20266,77429.7+0.0%
Mar 13, 20266,77329.10.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.